Hepatic Carcinoma

• CLINICAL_TRIALS trial_result · 2023-12-13
  Clinical Trial Update: to Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver Reserve [Phase 2]

  Phase 2 clinical trial assessing Ga68-Dolacga PET versus CT volumetry and ICG retention for measuring liver reserve in hepatic carcinoma.

• CLINICAL_TRIALS trial_result · 2023-11-13
  Clinical Trial Update: Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma [Phase 1]

  Phase 1 study assessing safety, pharmacokinetics, and pharmacodynamics of H3B-6527 in advanced hepatocellular carcinoma; trial completed wit…

• CLINICAL_TRIALS trial_result · 2023-10-17
  Clinical Trial Update: Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements. [Phase 2]

  Phase 2 clinical trial investigating octreotide for reducing blood loss and transfusion needs during laparoscopic hepatectomy in patients wi…

• CLINICAL_TRIALS trial_result · 2020-03-06
  Clinical Trial Update: Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy [Phase 4]

  Phase 4 trial update on Huaier Granule for preventing disease progression after non-radical hepatectomy in hepatic carcinoma; study terminat…

• CLINICAL_TRIALS trial_result · 2017-09-08
  Clinical Trial Update: The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection [Phase 4]

  Phase 4 trial investigating peginterferon alfa-2a on recurrence-free survival in subjects with hepatic carcinoma after surgical resection.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.